img

Global Japanese Encephalitis Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Japanese Encephalitis Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
The global Japanese Encephalitis Vaccines market size was US$ 208.6 million in 2022 and is forecast to a readjusted size of US$ 300.3 million by 2034 with a CAGR of 5.3% during the forecast period 2024-2034.
The United States market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Japanese Encephalitis Vaccines include Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, China National Biotec Group and Valneva Products, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Japanese Encephalitis Vaccines, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Japanese Encephalitis Vaccines by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Japanese Encephalitis Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Japanese Encephalitis Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
China National Biotec Group
Valneva Products
By Type
Attenuated Vaccines
Inactivated Vaccines
By Application
Adults
Children
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Japanese Encephalitis Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Japanese Encephalitis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Japanese Encephalitis Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Japanese Encephalitis Vaccines Definition
1.2 Market by Type
1.2.1 Global Japanese Encephalitis Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.3 Market Segment by Application
1.3.1 Global Japanese Encephalitis Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Japanese Encephalitis Vaccines Sales
2.1 Global Japanese Encephalitis Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Japanese Encephalitis Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Japanese Encephalitis Vaccines Revenue by Region
2.3.1 Global Japanese Encephalitis Vaccines Revenue by Region (2018-2024)
2.3.2 Global Japanese Encephalitis Vaccines Revenue by Region (2024-2034)
2.4 Global Japanese Encephalitis Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Japanese Encephalitis Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Japanese Encephalitis Vaccines Sales Quantity by Region
2.6.1 Global Japanese Encephalitis Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Japanese Encephalitis Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Japanese Encephalitis Vaccines Sales Quantity by Manufacturers
3.1.1 Global Japanese Encephalitis Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Japanese Encephalitis Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Japanese Encephalitis Vaccines Sales in 2022
3.2 Global Japanese Encephalitis Vaccines Revenue by Manufacturers
3.2.1 Global Japanese Encephalitis Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Japanese Encephalitis Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Japanese Encephalitis Vaccines Revenue in 2022
3.3 Global Japanese Encephalitis Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Japanese Encephalitis Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Japanese Encephalitis Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Japanese Encephalitis Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Japanese Encephalitis Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Japanese Encephalitis Vaccines Sales Quantity by Type
4.1.1 Global Japanese Encephalitis Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Japanese Encephalitis Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Japanese Encephalitis Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Japanese Encephalitis Vaccines Revenue by Type
4.2.1 Global Japanese Encephalitis Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Japanese Encephalitis Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Japanese Encephalitis Vaccines Price by Type
4.3.1 Global Japanese Encephalitis Vaccines Price by Type (2018-2024)
4.3.2 Global Japanese Encephalitis Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Japanese Encephalitis Vaccines Sales Quantity by Application
5.1.1 Global Japanese Encephalitis Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Japanese Encephalitis Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Japanese Encephalitis Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Japanese Encephalitis Vaccines Revenue by Application
5.2.1 Global Japanese Encephalitis Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Japanese Encephalitis Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Japanese Encephalitis Vaccines Price by Application
5.3.1 Global Japanese Encephalitis Vaccines Price by Application (2018-2024)
5.3.2 Global Japanese Encephalitis Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Japanese Encephalitis Vaccines Sales by Company
6.1.1 North America Japanese Encephalitis Vaccines Revenue by Company (2018-2024)
6.1.2 North America Japanese Encephalitis Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Japanese Encephalitis Vaccines Market Size by Type
6.2.1 North America Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Japanese Encephalitis Vaccines Revenue by Type (2018-2034)
6.3 North America Japanese Encephalitis Vaccines Market Size by Application
6.3.1 North America Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Japanese Encephalitis Vaccines Revenue by Application (2018-2034)
6.4 North America Japanese Encephalitis Vaccines Market Size by Country
6.4.1 North America Japanese Encephalitis Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Japanese Encephalitis Vaccines Revenue by Country (2018-2034)
6.4.3 North America Japanese Encephalitis Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Japanese Encephalitis Vaccines Sales by Company
7.1.1 Europe Japanese Encephalitis Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Japanese Encephalitis Vaccines Revenue by Company (2018-2024)
7.2 Europe Japanese Encephalitis Vaccines Market Size by Type
7.2.1 Europe Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Japanese Encephalitis Vaccines Revenue by Type (2018-2034)
7.3 Europe Japanese Encephalitis Vaccines Market Size by Application
7.3.1 Europe Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Japanese Encephalitis Vaccines Revenue by Application (2018-2034)
7.4 Europe Japanese Encephalitis Vaccines Market Size by Country
7.4.1 Europe Japanese Encephalitis Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Japanese Encephalitis Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Japanese Encephalitis Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Japanese Encephalitis Vaccines Sales by Company
8.1.1 China Japanese Encephalitis Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Japanese Encephalitis Vaccines Revenue by Company (2018-2024)
8.2 China Japanese Encephalitis Vaccines Market Size by Type
8.2.1 China Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Japanese Encephalitis Vaccines Revenue by Type (2018-2034)
8.3 China Japanese Encephalitis Vaccines Market Size by Application
8.3.1 China Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Japanese Encephalitis Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Japanese Encephalitis Vaccines Sales by Company
9.1.1 APAC Japanese Encephalitis Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Japanese Encephalitis Vaccines Revenue by Company (2018-2024)
9.2 APAC Japanese Encephalitis Vaccines Market Size by Type
9.2.1 APAC Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Japanese Encephalitis Vaccines Revenue by Type (2018-2034)
9.3 APAC Japanese Encephalitis Vaccines Market Size by Application
9.3.1 APAC Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Japanese Encephalitis Vaccines Revenue by Application (2018-2034)
9.4 APAC Japanese Encephalitis Vaccines Market Size by Region
9.4.1 APAC Japanese Encephalitis Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Japanese Encephalitis Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Japanese Encephalitis Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Sanofi Pasteur Japanese Encephalitis Vaccines Products and Services
11.1.5 Sanofi Pasteur Japanese Encephalitis Vaccines SWOT Analysis
11.1.6 Sanofi Pasteur Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 GlaxoSmithKline Japanese Encephalitis Vaccines Products and Services
11.2.5 GlaxoSmithKline Japanese Encephalitis Vaccines SWOT Analysis
11.2.6 GlaxoSmithKline Recent Developments
11.3 Bharat Biotech
11.3.1 Bharat Biotech Company Information
11.3.2 Bharat Biotech Overview
11.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Bharat Biotech Japanese Encephalitis Vaccines Products and Services
11.3.5 Bharat Biotech Japanese Encephalitis Vaccines SWOT Analysis
11.3.6 Bharat Biotech Recent Developments
11.4 China National Biotec Group
11.4.1 China National Biotec Group Company Information
11.4.2 China National Biotec Group Overview
11.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 China National Biotec Group Japanese Encephalitis Vaccines Products and Services
11.4.5 China National Biotec Group Japanese Encephalitis Vaccines SWOT Analysis
11.4.6 China National Biotec Group Recent Developments
11.5 Valneva Products
11.5.1 Valneva Products Company Information
11.5.2 Valneva Products Overview
11.5.3 Valneva Products Japanese Encephalitis Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Valneva Products Japanese Encephalitis Vaccines Products and Services
11.5.5 Valneva Products Japanese Encephalitis Vaccines SWOT Analysis
11.5.6 Valneva Products Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Japanese Encephalitis Vaccines Value Chain Analysis
12.2 Japanese Encephalitis Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Japanese Encephalitis Vaccines Production Mode & Process
12.4 Japanese Encephalitis Vaccines Sales and Marketing
12.4.1 Japanese Encephalitis Vaccines Sales Channels
12.4.2 Japanese Encephalitis Vaccines Distributors
12.5 Japanese Encephalitis Vaccines Customers
13 Market Dynamics
13.1 Japanese Encephalitis Vaccines Industry Trends
13.2 Japanese Encephalitis Vaccines Market Drivers
13.3 Japanese Encephalitis Vaccines Market Challenges
13.4 Japanese Encephalitis Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Attenuated Vaccines
Table 3. Major Manufacturers of Inactivated Vaccines
Table 4. Global Japanese Encephalitis Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Japanese Encephalitis Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Japanese Encephalitis Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2018-2024)
Table 8. Global Japanese Encephalitis Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2024-2034)
Table 10. Global Japanese Encephalitis Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Doses)
Table 11. Global Japanese Encephalitis Vaccines Sales by Region (2018-2024) & (K Doses)
Table 12. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2018-2024)
Table 13. Global Japanese Encephalitis Vaccines Sales by Region (2024-2034) & (K Doses)
Table 14. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2024-2034)
Table 15. Global Japanese Encephalitis Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Doses)
Table 16. Global Japanese Encephalitis Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Japanese Encephalitis Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Japanese Encephalitis Vaccines Revenue Share by Manufacturers (2018-2024)
Table 19. Global Japanese Encephalitis Vaccines Price by Manufacturers 2018-2024 (USD/Dose)
Table 20. Global Key Players of Japanese Encephalitis Vaccines, Industry Ranking, 2021 VS 2022
Table 21. Global Japanese Encephalitis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Japanese Encephalitis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Japanese Encephalitis Vaccines as of 2022)
Table 23. Global Key Manufacturers of Japanese Encephalitis Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Japanese Encephalitis Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Japanese Encephalitis Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 28. Global Japanese Encephalitis Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 29. Global Japanese Encephalitis Vaccines Sales Quantity Share by Type (2018-2024)
Table 30. Global Japanese Encephalitis Vaccines Sales Quantity Share by Type (2024-2034)
Table 31. Global Japanese Encephalitis Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Japanese Encephalitis Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Japanese Encephalitis Vaccines Revenue Share by Type (2018-2024)
Table 34. Global Japanese Encephalitis Vaccines Revenue Share by Type (2024-2034)
Table 35. Japanese Encephalitis Vaccines Price by Type (2018-2024) & (USD/Dose)
Table 36. Global Japanese Encephalitis Vaccines Price Forecast by Type (2024-2034) & (USD/Dose)
Table 37. Global Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 38. Global Japanese Encephalitis Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 39. Global Japanese Encephalitis Vaccines Sales Quantity Share by Application (2018-2024)
Table 40. Global Japanese Encephalitis Vaccines Sales Quantity Share by Application (2024-2034)
Table 41. Global Japanese Encephalitis Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Japanese Encephalitis Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Japanese Encephalitis Vaccines Revenue Share by Application (2018-2024)
Table 44. Global Japanese Encephalitis Vaccines Revenue Share by Application (2024-2034)
Table 45. Japanese Encephalitis Vaccines Price by Application (2018-2024) & (USD/Dose)
Table 46. Global Japanese Encephalitis Vaccines Price Forecast by Application (2024-2034) & (USD/Dose)
Table 47. North America Japanese Encephalitis Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Japanese Encephalitis Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 49. North America Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 50. North America Japanese Encephalitis Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 51. North America Japanese Encephalitis Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Japanese Encephalitis Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 54. North America Japanese Encephalitis Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 55. North America Japanese Encephalitis Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Japanese Encephalitis Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Japanese Encephalitis Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Japanese Encephalitis Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Japanese Encephalitis Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Japanese Encephalitis Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 61. North America Japanese Encephalitis Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 62. Europe Japanese Encephalitis Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 63. Europe Japanese Encephalitis Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 65. Europe Japanese Encephalitis Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 66. Europe Japanese Encephalitis Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Japanese Encephalitis Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 69. Europe Japanese Encephalitis Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 70. Europe Japanese Encephalitis Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Japanese Encephalitis Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Japanese Encephalitis Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Japanese Encephalitis Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Japanese Encephalitis Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Japanese Encephalitis Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 76. Europe Japanese Encephalitis Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 77. China Japanese Encephalitis Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 78. China Japanese Encephalitis Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 80. China Japanese Encephalitis Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 81. China Japanese Encephalitis Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Japanese Encephalitis Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 84. China Japanese Encephalitis Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 85. China Japanese Encephalitis Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Japanese Encephalitis Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Japanese Encephalitis Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 88. APAC Japanese Encephalitis Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 90. APAC Japanese Encephalitis Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 91. APAC Japanese Encephalitis Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Japanese Encephalitis Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 94. APAC Japanese Encephalitis Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 95. APAC Japanese Encephalitis Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Japanese Encephalitis Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Japanese Encephalitis Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Japanese Encephalitis Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Japanese Encephalitis Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Japanese Encephalitis Vaccines Sales Quantity by Region (2018-2024) & (K Doses)
Table 101. APAC Japanese Encephalitis Vaccines Sales Quantity by Region (2024-2034) & (K Doses)
Table 102. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 103. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 105. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 106. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 109. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 110. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 116. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 117. Sanofi Pasteur Company Information
Table 118. Sanofi Pasteur Description and Overview
Table 119. Sanofi Pasteur Japanese Encephalitis Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 120. Sanofi Pasteur Japanese Encephalitis Vaccines Product and Services
Table 121. Sanofi Pasteur Japanese Encephalitis Vaccines SWOT Analysis
Table 122. Sanofi Pasteur Recent Developments
Table 123. GlaxoSmithKline Company Information
Table 124. GlaxoSmithKline Description and Overview
Table 125. GlaxoSmithKline Japanese Encephalitis Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 126. GlaxoSmithKline Japanese Encephalitis Vaccines Product and Services
Table 127. GlaxoSmithKline Japanese Encephalitis Vaccines SWOT Analysis
Table 128. GlaxoSmithKline Recent Developments
Table 129. Bharat Biotech Company Information
Table 130. Bharat Biotech Description and Overview
Table 131. Bharat Biotech Japanese Encephalitis Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 132. Bharat Biotech Japanese Encephalitis Vaccines Product and Services
Table 133. Bharat Biotech Japanese Encephalitis Vaccines SWOT Analysis
Table 134. Bharat Biotech Recent Developments
Table 135. China National Biotec Group Company Information
Table 136. China National Biotec Group Description and Overview
Table 137. China National Biotec Group Japanese Encephalitis Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 138. China National Biotec Group Japanese Encephalitis Vaccines Product and Services
Table 139. China National Biotec Group Japanese Encephalitis Vaccines SWOT Analysis
Table 140. China National Biotec Group Recent Developments
Table 141. Valneva Products Company Information
Table 142. Valneva Products Description and Overview
Table 143. Valneva Products Japanese Encephalitis Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 144. Valneva Products Japanese Encephalitis Vaccines Product and Services
Table 145. Valneva Products Japanese Encephalitis Vaccines SWOT Analysis
Table 146. Valneva Products Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Japanese Encephalitis Vaccines Distributors List
Table 150. Japanese Encephalitis Vaccines Customers List
Table 151. Japanese Encephalitis Vaccines Market Trends
Table 152. Japanese Encephalitis Vaccines Market Drivers
Table 153. Japanese Encephalitis Vaccines Market Challenges
Table 154. Japanese Encephalitis Vaccines Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Japanese Encephalitis Vaccines Product Picture
Figure 2. Global Japanese Encephalitis Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Japanese Encephalitis Vaccines Market Share by Type in 2022 & 2034
Figure 4. Attenuated Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Global Japanese Encephalitis Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Japanese Encephalitis Vaccines Market Share by Application in 2022 & 2034
Figure 8. Adults
Figure 9. Children
Figure 10. Japanese Encephalitis Vaccines Report Years Considered
Figure 11. Global Japanese Encephalitis Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Japanese Encephalitis Vaccines Revenue 2018-2034 (US$ Million)
Figure 13. Global Japanese Encephalitis Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Japanese Encephalitis Vaccines Sales Quantity 2018-2034 (K Doses)
Figure 15. Global Japanese Encephalitis Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 16. Global Japanese Encephalitis Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Japanese Encephalitis Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 18. North America Japanese Encephalitis Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Japanese Encephalitis Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 20. Europe Japanese Encephalitis Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Japanese Encephalitis Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 22. China Japanese Encephalitis Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Japanese Encephalitis Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 24. APAC Japanese Encephalitis Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 26. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Japanese Encephalitis Vaccines Sales Quantity in 2022
Figure 28. The Top 10 and Top 5 Players Market Share by Japanese Encephalitis Vaccines Revenue in 2022
Figure 29. Japanese Encephalitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Japanese Encephalitis Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2034)
Figure 32. Global Japanese Encephalitis Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2018-2034)
Figure 34. North America Japanese Encephalitis Vaccines Revenue Market Share by Company in 2022
Figure 35. North America Japanese Encephalitis Vaccines Sales Quantity Market Share by Company in 2022
Figure 36. North America Japanese Encephalitis Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2034)
Figure 38. North America Japanese Encephalitis Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Japanese Encephalitis Vaccines Revenue Market Share by Application (2018-2034)
Figure 40. North America Japanese Encephalitis Vaccines Revenue Share by Country (2018-2034)
Figure 41. North America Japanese Encephalitis Vaccines Sales Quantity Share by Country (2018-2034)
Figure 42. U.S. Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Japanese Encephalitis Vaccines Sales Quantity Market Share by Company in 2022
Figure 45. Europe Japanese Encephalitis Vaccines Revenue Market Share by Company in 2022
Figure 46. Europe Japanese Encephalitis Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2034)
Figure 48. Europe Japanese Encephalitis Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Japanese Encephalitis Vaccines Revenue Market Share by Application (2018-2034)
Figure 50. Europe Japanese Encephalitis Vaccines Revenue Share by Country (2018-2034)
Figure 51. Europe Japanese Encephalitis Vaccines Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 53. France Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. China Japanese Encephalitis Vaccines Sales Quantity Market Share by Company in 2022
Figure 58. China Japanese Encephalitis Vaccines Revenue Market Share by Company in 2022
Figure 59. China Japanese Encephalitis Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2034)
Figure 61. China Japanese Encephalitis Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Japanese Encephalitis Vaccines Revenue Market Share by Application (2018-2034)
Figure 63. APAC Japanese Encephalitis Vaccines Sales Quantity Market Share by Company in 2022
Figure 64. APAC Japanese Encephalitis Vaccines Revenue Market Share by Company in 2022
Figure 65. APAC Japanese Encephalitis Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2034)
Figure 67. APAC Japanese Encephalitis Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Japanese Encephalitis Vaccines Revenue Market Share by Application (2018-2034)
Figure 69. APAC Japanese Encephalitis Vaccines Revenue Share by Region (2018-2034)
Figure 70. APAC Japanese Encephalitis Vaccines Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. India Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity Market Share by Company in 2022
Figure 77. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Japanese Encephalitis Vaccines Revenue Share by Country (2018-2034)
Figure 84. Brazil Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Japanese Encephalitis Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Japanese Encephalitis Vaccines Value Chain
Figure 90. Japanese Encephalitis Vaccines Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries